EYEG Overview
Upcoming Projects (EYEG)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (EYEG)
-
What's the market potential of EyeGate Ocular Bandage Gel now that the FDA has agreed to review it via the De Novo 510(k) pathway.
Ticker: EYEG
Execute By: Feb 12, 2017
Upcoming & Overdue Catalysts (EYEG)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (EYEG)
-
EyeGate (EYEG) Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
Ticker: EYEG
Occurred on: Feb 05, 2018 -
EyeGate Announces $3.77 Million Registered Direct Offering
Ticker: EYEG
Occurred on: Jun 27, 2016 -
EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437
Tickers: EYEG, VRX
Occurred on: Mar 02, 2016
Strategic Initiatives (EYEG)
-
EyeGate Pharma (EYEG) Announces Acquisition of Panoptes Pharma to Expand Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage DHODH Inhibitor
Tickers: EYEG, Panoptes Pharma
Announcement Date: Dec 21, 2020 -
Subsidiary of Valeant (VRX) and EyeGate (EYEG) Announce Exclusive Global Licensing Agreement for EGP-437 and EyeGate II Delivery System in Ocular Surgery
Tickers: VRX, EYEG
Announcement Date: Feb 21, 2017
